DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - News

 
 



News related to Erbitux (Cetuximab) and/or conditions it is approved for

In KRAS wild-type MCRC, equivalent survival offered by cetuximab or bevacizumab with combi chemo
Source: Colorectal Cancer News From Medical News Today [2014.07.01]
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress...

New study data find Avastin® (bevacizumab) and cetuximab help patients with KRAS wild-type advanced bowel cancer live similar length of time
Source: Colorectal Cancer News From Medical News Today [2014.06.04]
CALGB 80405, a large, independent, phase III study, designed to assess the superiority in overall survival (OS) of cetuximab over Avastin® (bevacizumab) when combined with either FOLFOX or...

Innovative methodology enables non-coding DNA to be decoded in colorectal cancer
Source: Cancer / Oncology News From Medical News Today [2014.07.25]
Cancer is a disease of the genome resulting from a combination of genetic modifications (or mutations).

Carbs turned into colorectal cancer by gut microbes in those predisposed to the disease
Source: Colorectal Cancer News From Medical News Today [2014.07.21]
Colorectal cancer has been linked to carbohydrate-rich western diets, but the underlying mechanisms have been unclear.

Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to standard therapies
Source: Colorectal Cancer News From Medical News Today [2014.06.30]
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the...

Half a million cancers prevented by colorectal cancer screening
Source: Colorectal Cancer News From Medical News Today [2014.06.05]
An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness...

For some, screening for colorectal cancer should continue well past age 75
Source: Colorectal Cancer News From Medical News Today [2014.06.02]
Colorectal cancer (CRC) screening is cost-effective in elderly patients and should continue well past age 75 for those who have not already been screened, according to an article being published in...

FDA approves first-line use of Vectibix® (panitumumab) plus FOLFOX for patients with wild-type KRAS metastatic colorectal cancer
Source: Colorectal Cancer News From Medical News Today [2014.05.28]
Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved Vectibix® (panitumumab) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as...

Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Source: MedicineNet Rectal Bleeding Specialty [2013.06.07]
Title: Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Category: Slideshows
Created: 9/21/2009 12:59:00 PM
Last Editorial Review: 6/7/2013 12:00:00 AM

Antidepressants might reduce risk of colorectal cancer
Source: The Doctors Lounge - Psychiatry
Use of serotonin reuptake inhibitors (SSRI) might inhibit the growth of colorectal tumors according to The Lancet Oncology.

Promising response to new combination therapy by patients with metastatic colon cancer
Source: Colorectal Cancer News From Medical News Today [2014.06.03]
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014